๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
NCT07492927Clinically Significant Prostate Cancer
Xijing Hospital
Observational
1,700
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yanโ€™an
2021-03-12
By invitation
Plasma Exosome RNA to Diagnose Prostate Cancer
NCT06604130Prostate Cancer
Xijing Hospital
Not applicable
1,600
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yanโ€™an
2021-03-12
Active, closed
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
NCT04562389Myelofibrosis
Karyopharm Therapeutics Inc
Phase 3
353
2021-03-11
Recruiting
Topotecan and Melphalan for Retinoblastoma
NCT04799002Retinoblastoma, Chemotherapy Effect
Sun Yat-sen University
Phase 3
50
Guangzhou
2021-03-11
Not yet open
Precision Medicine Study on Cardiovascular Disease (PRECISE)
NCT04434911Cardiovascular Diseases
China National Center for Cardiovascular Diseases
Observational
20,000
Beijing
2021-03-10
Active, closed
Phase I Clinical Trial of CT0180 Cells in the Treatment of Hepatocellular Carcinoma
NCT04756648Advanced Hepatocellular Carcinoma
Zhejiang University
Phase 1
21
Hangzhou
2021-03-10
Recruiting
A Clinical Study to Evaluate Efficacy and Safety of Serplulimab๏ผˆHLX10๏ผ‰ Combined With Bevacizumab๏ผˆHLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)
NCT04547166Metastatic Colorectal Cancer
Shanghai Henlius Biotech
Phase 2/3
568
Guangzhou, Hangzhou, Linyi, Shanghai
2021-03-10
Recruiting
Long-term Remote Ischemic Preconditioning Improves Myocardial Perfusion and Prognosis of Patients After CABG
NCT04779008Coronary Disease
Henan Institute of Cardiovascular Epidemiology
Not applicable
210
Zhengzhou
2021-03-10
Recruiting
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
NCT04686305Locally Advanced or Metastatic Non-Small Cell Lung Cancer
AstraZeneca
Phase 1
304
Changchun, Chengdu, Fuzhou, Shandong, Shanghai, Zhengzhou
2021-03-09
Recruiting
PM8002 in the Treatment of Patients With Advanced Solid Tumors
NCT05918445Malignant Neoplasm
Biotheus Inc.
Phase 1/2
380
Baoji, Beijing, Changchun, Changde, Changsha, Changzhou, Chengdu, Chongqing
2021-03-09
Active, closed
Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT04666038Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Loxo Oncology, Inc.
Phase 3
238
Beijing, Xicheng District, Lanzhou, Guangzhou, Haikou, Zhengzhou, Changsha, Xuzhou
2021-03-09
Recruiting
a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease
NCT04776330Multiple Myeloma, Neoplasm, Plasma Cell, Multiple Myeloma in Relapse
Chongqing Precision Biotech Co., Ltd
Phase 1/2
80
Kunming
2021-03-07
Recruiting
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
NCT07553780High-risk Prostate Cancer, PSMA PET, Treatment Response, Therapy Monitoring
Xijing Hospital
Observational
110
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yanโ€™an
2021-03-07
Recruiting
a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL
NCT04781634B-ALL
Chongqing Precision Biotech Co., Ltd
Phase 1/2
40
Kunming
2021-03-07
Recruiting
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naรฏve Men With Suspected Prostate Cancer
NCT07531329Treatment-naive Prostate Cancer, Suspected Prostate Cancer, Molecular Imaging
Xijing Hospital
Observational
1,000
Lanzhou, Yinchuan, Xining, Weinan, Xi'an, Xianyang, Yanโ€™an
2021-03-05
Active, closed
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
NCT04582136Systemic Lupus Erythematosus
Chinese SLE Treatment And Research Group
Phase 3
146
Beijing, Shenzhen, Zhengzhou, Nanchang, Shenyang, Kunming
2021-03-04
Recruiting
Gene Therapy for Chinese Hemophilia A
NCT04728841Hemophilia A, Gene Therapy
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
12
Tianjin
2021-03-04
Recruiting
Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.
NCT04778839Advanced Solid Tumors
First Affiliated Hospital of Zhejiang University
Phase 1
98
Hanzhou
2021-03-04
Recruiting
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
NCT04710576Chronic Graft-versus-host-disease
Syndax Pharmaceuticals
Phase 2
296
2021-03-04
Active, closed
Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke
NCT04479722Atrial Fibrillation, Stroke
Shanghai MicroPort Medical (Group) Co., Ltd.
Not applicable
210
Shanghai
2021-03-03
Recruiting
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma
NCT04778956Nasopharyngeal Carcinoma, PD-1, Surgery
Sun Yat-sen University
Phase 3
218
Guangzhou, Zhongshan, Nanchang
2021-03-03
Recruiting
Evaluating Omitting of Internal Mammary Irradiation Among Early Stage Intermediate Risk (N1) Breast Cancer
NCT04517266Breast Cancer
Ruijin Hospital
Not applicable
214
Shanghai
2021-03-01
Active, closed
Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)
NCT04765657Hypercholesterolemia
Novartis Pharmaceuticals
Phase 3
345
Lanzhou, Foshan, Guangzhou, Shijiazhuang, Baotou, Hohhot, Nanjing, Nantong
2021-03-01
Recruiting
Aortic Valve Diseases RISk facTOr assessmenT and Prognosis modeL Construction
NCT06069232Aortic Valve Disease
Sun Yat-sen University
Observational
2,000
Guangzhou, Jieyang, Shantou, Shenzhen, Zhanjiang, Zhongshan
2021-03-01
Recruiting
China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine
NCT04885374Amyotrophic Lateral Sclerosis
Dongzhimen Hospital, Beijing
Observational
2,000
Beijing
2021-03-01
Recruiting
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
NCT07080437Esophageal Squamous Cell Carcinoma (ESCC)
Three Gorges Hospital of Chongqing University
Observational
40
Chongqing
2021-03-01
Recruiting
The Effect of Sirolimus on Immunizations During the Treatment of Kaposiform Hemangioendothelioma
NCT05351216Kaposiform Hemangioendothelioma
Children's Hospital of Fudan University
Observational
174
Shanghai
2021-03-01
Recruiting
A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC)
NCT06749015Metastatic Colorectal Cancer, BRAF V600 Mutation
Fudan University
Observational
100
Shanghai
2021-03-01
Recruiting
Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors
NCT04952272Lung Cancer, Hepatocellular Carcinoma, Solid Tumor
Second Affiliated Hospital of Guangzhou Medical University
Phase 1
50
Guangzhou
2021-03-01
Recruiting
Psychological Screening and Nursing of Twin Pregnancy
NCT05182541Twin; Complicating Pregnancy, Psychology
Shengjing Hospital
Not applicable
100
Shenyang
2021-03-01
Recruiting
The Study of Electrical Acupuncture Stimulation Therapy for Postprostatectomy Incontinence
NCT04972669Postprostatectomy Incontinence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
110
Nanjing
2021-03-01
Recruiting
Neoadjuvant Radiation in Locally Advanced Breast Cancer
NCT05479409Breast Neoplasms
Fudan University
Phase 2
70
Shanghai
2021-03-01
Recruiting
Carilizumab and Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
NCT07320586Gastric Cancer, Second-line Therapy
Shandong Tumor Hospital
Phase 2
40
Jinan
2021-03-01
Active, closed
CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL
NCT04881838Pediatric Anaplastic Large Cell Lymphoma
Children's Cancer Group, China
Phase 3
172
Shanghai
2021-03-01
Recruiting
Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
NCT04535661Carbapenem-Resistant Enterobacteriaceae Infection
Children's Hospital of Fudan University
Observational
536
Shanghai
2021-03-01
Recruiting
Efficacy and Safety of Auto-FMT in Preventing aGVHD
NCT04745221Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University
Not applicable
100
Suzhou
2021-03-01
Active, closed
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
NCT05400070Sintilimab, Lung Cancer, Anlotinib, Chemotherapy
Tang-Du Hospital
Phase 2
45
Xi'an
2021-03-01
Recruiting
Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis
NCT04847752Ischemic Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis)
Tongji Hospital
Observational
1,000
Wuhan
2021-03-01
Recruiting
A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy
NCT04478292Hepatoblastoma
Shanghai Children's Medical Center
Phase 3
330
Shanghai
2021-03-01
Not yet open
Total Robotic Versus Robotic Assisted Distal Gastrectomy for Gastric Cancer
NCT04795063Gastric Cancer, Robotic Gastrectomy
Fujian Medical University
Not applicable
160
Fuzhou
2021-03-01
By invitation
Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer Patients
NCT07751757Neoplasm
Chinese PLA General Hospital
Observational
1,500
Beijing
2021-03-01
Not yet open
Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT
NCT04215510Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Phase 3
286
Fuzhou, Nanchang, Shanghai
2021-03-01
Recruiting
Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma
NCT04331093Acral Melanoma
Di Wu
Phase 2
40
Changchun
2021-03-01
Recruiting
China Monogenic Diabetes Registry
NCT07492004Neonatal Diabetes, Monogenic Diabetes, Maturity Onset Diabetes of the Young
Tianjin Medical University General Hospital
Observational
5,000
Tianjin
2021-02-28
Recruiting
Health ImprOvement Program of Bone in China
NCT05906147Osteoporosis
Second Xiangya Hospital of Central South University
Observational
5,000
Changsha
2021-02-27
Active, closed
Cohort Study of Airway Microecology and the Pathogenesis and Evolution of Chronic Obstructive Pulmonary Disease
NCT04849104Chronic Obstructive Pulmonary Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
210
Shanghai
2021-02-26
Recruiting
Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Sintilimab in Clinical Practice Among Chinese Patients
NCT04840355Immune Related Adverse Events, PD-1
Guohui Li
Observational
100
Beijing
2021-02-26
Active, closed
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
NCT04717414Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis
Celgene
Phase 3
313
Guangzhou, Nanyang, Changsha, Nanjing, Nantong, Nanchang, Qingdao, Taiyuan
2021-02-25
Active, closed
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT04699188KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung, Carcinoma, Colorectal, Cancer of Lung
Novartis Pharmaceuticals
Phase 1/2
344
Guangzhou, Beijing
2021-02-24
Active, closed
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT04408638Diffuse Large B-cell Lymphoma
Hoffmann-La Roche
Phase 3
270
Beijing, Guangzhou, Harbin, Shanghai, Tianjin, Wuhan, Zhejiang, Zhengzhou
2021-02-23
Active, closed
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
NCT04279847Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm
Incyte Corporation
Phase 1
140
Beijing, Guangzhou, Hangzhou, Zhengzhou
2021-02-23
Active, closed
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
NCT04685135Metastatic Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer
Mirati Therapeutics Inc.
Phase 3
453
Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Liuzhou, Harbin, Xinxiang
2021-02-23
Recruiting
68Ga-FAPI PET/CT in Malignant Tumors
NCT05034146Fibroblast Activation Protein Inhibitor, PET/CT, Malignant Neoplasm
Zhongnan Hospital
Not applicable
500
Wuhan
2021-02-23
Active, closed
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A
NCT04644575Hemophilia A
Bioverativ, a Sanofi company
Phase 3
261
Beijing, Guangzhou, Hangzhou, Jinan, Kunming, Lanzhou, Suzhou
2021-02-23
Recruiting
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
NCT04777942Hepatocellular Carcinoma
Sun Yat-sen University
Not applicable
320
Guangzhou
2021-02-20
Recruiting
Prospective Cohort Study on the Relationship Between Exosomal Peroxiredoxin 1 (PRDX1) and Postoperative Liver Metastasis
NCT07177742Colorectal Cancer, Liver Metastases From Colorectal Cancer, Pathology, Exosome
Mu-qing Yang
Observational
260
Shanghai
2021-02-15
Recruiting
Pathogenic Metagenomic Next-generation Sequencing to Optimize the Diagnosis of Decompensated Cirrhosis Infection
NCT06039696Cirrhosis, Liver
Nanfang Hospital, Southern Medical University
Observational
850
Guangzhou
2021-02-10
Recruiting
Impact of Remimazolam on Prognosis After Bladder Cancer Surgery
NCT04532606Benzodiazepines, Bladder Cancer, Delirium, Surgery
Peking University First Hospital
Phase 4
1,128
Beijing, Beijin, Guiyang, Nanjing, Shanghai
2021-02-05
Active, closed
HERTHENA-Lung01: Patritumab Deruxtecan in Subjects With Metastatic or Locally Advanced EGFR-mutated Non-Small Cell Lung Cancer
NCT04619004Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
Daiichi Sankyo
Phase 2
277
Beijing, Changchun, Chengdu, Guangzhou, Hangzhou, Harbin, Nanjing, Shanghai
2021-02-02
Not yet open
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
NCT04736589Breast Cancer
Peking Union Medical College
Phase 3
270
Beijing
2021-02-02
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
NCT04634552Hematological Malignancies
Janssen Research & Development, LLC
Phase 2
510
Beijing, Guangzhou, Hangzhou, Suzhou, Tianjin, Xi'an
2021-02-01
Recruiting
Research on the Mechanism Affecting Progression of Bronchiectasis
NCT05731427Bronchiectasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
150
Guiyang, Wuhan, Yichang
2021-02-01
Recruiting
Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)
NCT04230447Sepsis-Associated Encephalopathy
Yi Li, MD
Observational
3,000
Beijing
2021-02-01
Active, closed
A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLC
NCT04736823NSCLC
Akeso
Phase 2
265
Guanzhou
2021-02-01
Recruiting
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT05183074Prostate Cancer, Radiotherapy Side Effect, Magnetic Resonance-linac, Stereotactic Ablative RT
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
50
Beijing
2021-02-01
Recruiting
Protective Effect of CoQ10 Against Negative Inflammatory Response and Organ Dysfunction in Cardiovascular Surgery (PANDA V)
NCT04444349Cardiovascular Disease
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu
2021-02-01
Recruiting
Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
NCT04733820Uterine Cervical Neoplasms, Cervical Cancer
Huazhong University of Science and Technology
Phase 3
340
Wuhan
2021-02-01
Recruiting
Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture
NCT04723888Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter
RenJi Hospital
Not applicable
300
Shanghai
2021-02-01
Recruiting
Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention
NCT04240834Acute Coronary Syndrome, Interventional Cardiology
Fu Wai Hospital, Beijing, China
Phase 4
1,220
Beijing
2021-02-01
Recruiting
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932Immune System and Related Disorders
RenJi Hospital
Observational
50
Shanghai
2021-02-01
Active, closed
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
NCT04561739De Novo Stenosis, Coronary Artery Disease
Xijing Hospital
Not applicable
2,272
Xi'an
2021-02-01
Active, closed
A Study of Endovascular Treatment of Femoropopliteal Arterial Occlusive Lesion With Drug-Coated Balloon
NCT04826705Drug-coated Balloon, Femoropopliteal Artery Occlusion, Angioplasty
Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology
Observational
2,000
Wuhan, Beijing, Chengdu, Hangzhou, Qingdao, Shanghai, Suzhou
2021-02-01
Recruiting
Raman Spectroscopy Diagnosis of Kidney Diseases
NCT06760845IgA Nephropathy (IgAN), Membranous Nephropathy, Diabetic Nephropathy, Focal Segmental Glomerulosclerosis (FSGS)
Zunsong Wang
Observational
200
Jinan
2021-02-01
Recruiting
Safety and Efficacy of Stereotactic Aspiration Plus Urokinase in Deep Intracerebral Hemorrhage Evacuation
NCT04686877Treatment of Spontaneous Intracerebral Hemorrhage
First Affiliated Hospital of Fujian Medical University
Not applicable
400
Fuzhou
2021-01-31
Recruiting
Lymphadenectomy in Early Ovarian Cancer
NCT04710797Ovarian Cancer, Lymphadenectomy
Sun Yat-sen University
Not applicable
656
Guangzhou
2021-01-31
Recruiting
Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy
NCT05552846Small-cell Lung Cancer
Ruijin Hospital
Not applicable
104
Shanghai
2021-01-30
Recruiting
Clinical Treatment of Transcranial Direct Current Stimulation in Older Adolescents With Amblyopia
NCT06760910Amblyopia
Tianjin Eye Hospital
Not applicable
40
Tianjin
2021-01-30
Recruiting
Morning Versus Bedtime Dosing of Antihypertensive Medication
NCT05089448Hypertension, Blood Pressure, Drug Use
Yan Li
Phase 4
300
Shanghai
2021-01-28
Active, closed
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline
NCT04723875Uterine Cervical Neoplasms, Cervical Cancer
Huazhong University of Science and Technology
Phase 3
306
Wuhan, Ji'nan, Hangzhou
2021-01-28
Active, closed
A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT04632108Malignant Solid Tumor
Jiangsu Aosaikang Pharmaceutical Co., Ltd.
Phase 1/2
199
Beijing, Linyi
2021-01-28
Active, closed
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
NCT04711252ER-Positive HER2-Negative Breast Cancer
AstraZeneca
Phase 3
1,370
Baoding, Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dalian
2021-01-28
Active, closed
Intracorporeal Anastomosis Versus Extracorporeal Anastomosis for Left Colon Cancer
NCT04201717Colon Cancer
Jilin University
Not applicable
350
Changchun, Beijing, Chongqing, Guangzhou, Shanghai, Shenyang
2021-01-27
Recruiting
Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications
NCT04721041Intestinal Complications, Cancer
The Second Hospital of Nanjing Medical University
Not applicable
200
Nanjing
2021-01-26
Active, closed
Super Hypofractionated Irradiation for Whole Breast Treatment
NCT04926766Breast Cancer
Ruijin Hospital
Not applicable
217
Shanghai
2021-01-23
Active, closed
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma
NCT04718415Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
51
Guangzhou, Guanzhou
2021-01-23
Recruiting
Effects of Lifestyle Intervention on Childhood Outcomes in LGA Infants
NCT04661449Childhood Overweight
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
138
Shanghai
2021-01-22
Recruiting
Assessment of Pancreatic Physiological and Pathological Characteristics Based on Spectral CT
NCT06510036Diagnose Disease
Yu Shi
Observational
1,500
Shenyang
2021-01-21
Recruiting
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT04415853Esophageal Cancer
Sunshine Lake Pharma Co., Ltd.
Phase 3
416
Beijing
2021-01-21
Active, closed
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer
NCT04509648Breast Cancer
Ruijin Hospital
Not applicable
197
Shanghai
2021-01-21
Active, closed
Phase II-III Clinical Trial of PD1 Antibody (Toripalimab), Lenvatinib and GEMOX Neoadjuvant Treatment for Resectable Intrahepatic Cholangiocarcinoma With High-risk Recurrence Factors
NCT04669496Intrahepatic Cholangiocarcinoma, PD1 Antibody, Lenvatinib, Gemox Chemotherapy
Shanghai Zhongshan Hospital
Phase 2/3
178
Shanghai
2021-01-20
Active, closed
Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer
NCT04544189Breast Neoplasms
Novartis Pharmaceuticals
Phase 2
69
Hefei, Guangzhou, Shijiazhuang, Harbin, Zhengzhou, Wuhan, Changsha, Nanjing
2021-01-20
Recruiting
Multicenter Study on Laparoscopic Total Gastrectomy for Advanced Gastric Cancer
NCT04710758Stomach Neoplasms
Shanghai Zhongshan Hospital
Not applicable
1,018
Shanghai
2021-01-20
Active, closed
PrizValveยฎ Transcatheter Aortic Valve Replacement Study
NCT04836897Aortic Valve Stenosis
Shanghai NewMed Medical Co., Ltd.
Not applicable
120
Sichuan
2021-01-19
Recruiting
A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
NCT05098769Pulmonary Embolism and Thrombosis, Deterioration, Clinical
Shengjing Hospital
Observational
300
Shenyang
2021-01-18
Active, closed
Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
NCT04589845Solid Tumors
Hoffmann-La Roche
Phase 2
920
Beijing, Chengdu, Shanghai, Tianjin, Xi'an
2021-01-18
Not yet open
NKG2D CAR-T Cell Therapy for Patients With Relapsed and/or Refractory Acute Myeloid Leukemia
NCT04658004Acute Myeloid Leukemia
Zhejiang University
Phase EARLY_PHASE1
36
Hangzhou
2021-01-15
Recruiting
Efficacy and Safety of Fecal Microbiota Transplantation
NCT04706611Fecal Microbiota Transplantation
Guangzhou First People's Hospital
Not applicable
300
Guangzhou
2021-01-15
Not yet open
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies
NCT04657965Infectious Diseases, Hematological Malignancies
Zhejiang University
Phase EARLY_PHASE1
144
Hangzhou
2021-01-15
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
NCT04649242Pediatric Migraine
Pfizer
Phase 3
2,100
Bengbu, Hefei, Beijing, Chongqing, Lanzhou, Shenzhen, Haikou, Shijiazhuang
2021-01-15
Recruiting
Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
NCT04687631Colorectal Cancer, Liver Metastases
Fudan University
Phase 3
508
Shanghai
2021-01-14
Rows per page Showing 17601–17700 of 19052
Previous 175 176 177 178 179 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=177

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.